|
Erlotinib Clinical Trials
6 actively recruiting trials across 2 locations
Also known as: Tarceva
Pipeline
Phase 2: 4Phase 1/2: 1
Top Sponsors
- Ulrik Lassen1
- UNC Lineberger Comprehensive Cancer Center1
- The Netherlands Cancer Institute1
- Seoul National University Bundang Hospital1
- National Cancer Institute (NCI)1
Indications
- Cancer6
- Neoplasia2
- Tumors2
- Sporadic Papillary Renal Cell Carcinoma1
- Hereditary Leiomyomatosis and Renal Cell Carcinoma1
Other4 trials
La Jolla, California1 trial
Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer
UC San Diego Moores Cancer Center
Phase 2
Chapel Hill, North Carolina1 trial
Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel
University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.